compare_entities
Exposed by 1313 servers, with 2 different definitions behind the one name.
The same name does not mean the same tool here.
1313 servers expose compare_entities and we have recorded 2 distinct definitions of it. Compare the parameters below before assuming one is a drop-in for another.
Kitsu anime + manga catalogue (JSON:API)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Lens.org patent + scholarly search (free academic key required)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
LibreTranslate MCP — open-source machine translation (BYO endpoint)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NYPL Digital Collections MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NYT MCP — wraps The New York Times Developer APIs (developer.nytimes.com)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
open.canada.ca — Canada national open-data catalogue (CKAN)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Outlook Calendar MCP Pack
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
OWID MCP — Our World in Data chart/indicator access (free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
PubMed MCP — wraps the NCBI E-utilities API (biomedical literature, free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
SAM.gov MCP — Federal contract opportunities and entity registration data
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Scrapingdog MCP — wraps Scrapingdog (scrapingdog.com), a proxy-based web
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
send-that-email MCP — wraps StupidAPIs (requires X-API-Key)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Social Signal — post-VOLUME TIME SERIES across the open social networks that
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Sports Game Odds MCP — wraps the Sports Game Odds API (sportsgameodds.com)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
StackExchange MCP — wraps the StackExchange API v2.3 (free, no auth required for read)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Statistics Estonia (andmed.stat.ee) PxWeb MCP. Keyless.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
TED MCP — Tenders Electronic Daily (EU public procurement)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Victoria and Albert Museum (V&A) Collections MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Wikidata SPARQL MCP — Wikidata Query Service
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Wiktionary MCP — multilingual dictionary via Wikimedia REST + MediaWiki Action API
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
What this page is
Every field above is reproduced as the server published it at the time shown. The description and the annotations are claims by the server's author. Toolpin does not call tools, so we cannot tell you whether a tool does what it says.
What we can tell you is whether the claim changed. The hash covers the fields the MCP specification defines, so a vendor build stamp does not move it but a rewritten description does. See how we monitor, or this server's change history.